Akebia Therapeutics
AKBA
#6967
Rank
A$0.61 B
Marketcap
$2.94
Share price
4.02%
Change (1 day)
110.22%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -$0.97

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.97. In 2022 the company made an earnings per share (EPS) of -$0.77 an increase over its 2021 EPS that were of -$2.58.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.9725.32%
2022-$0.77-70%
2021-$2.58-38.63%
2020-$4.2017.37%
2019-$3.582.79%
2018-$3.4831.2%
2017-$2.65-51.39%
2016-$5.4657.89%
2015-$3.46-94.83%
2014-$66.88589.75%
2013-$9.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$21.45-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.67-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$21.36-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.47 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA